Transint™ Platform

The TRANSINT™ platform directs safe, efficient delivery of biological payloads across epithelial cells to local GI submucosal tissue, the epicenter of the immune system for engaging mucosal immunology pathways to correct dysregulation. The technology is also capable of releasing payloads into the bloodstream.